These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12080274)

  • 1. Yasmin--an oral contraceptive with a new progestin.
    Med Lett Drugs Ther; 2002 Jun; 44(1133):55-7. PubMed ID: 12080274
    [No Abstract]   [Full Text] [Related]  

  • 2. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is [symbol: see text] Yasmin a "truly different" pill?
    Drug Ther Bull; 2002 Aug; 40(8):57-9. PubMed ID: 12216337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of a new oral contraceptive containing drospirenone.
    Shulman LP
    J Reprod Med; 2002 Nov; 47(11 Suppl):981-4. PubMed ID: 12497672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.
    Dickerson V
    J Reprod Med; 2002 Nov; 47(11 Suppl):985-93. PubMed ID: 12497673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yasmin: the reason why.
    Thorneycroft IH
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():13-8; discussion 42-3. PubMed ID: 12659402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolism associated with the new contraceptive Yasmin.
    van Grootheest K; Vrieling T
    BMJ; 2003 Feb; 326(7383):257. PubMed ID: 12560278
    [No Abstract]   [Full Text] [Related]  

  • 8. The risk of deep venous thrombosis with oral contraceptives containing drospirenone.
    Dunn N
    BMJ; 2011 Apr; 342():d2519. PubMed ID: 21511807
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone.
    Oelkers W
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():19-26; discussion 42-3. PubMed ID: 12659403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The truth about oral contraceptives and venous thromboembolism.
    Shulman LP; Goldzieher JW
    J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
    Milsom I; Odlind V; von Schoultz B; Ostlund I; Persson E
    Lakartidningen; 2002 Jan; 99(1-2):10-2, 15. PubMed ID: 11871161
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient ischaemic attack associated with the new contraceptive Yasmin.
    Vayá A; Mira Y; Ferrando F; Aznar J; García-Fuster MJ
    Thromb Res; 2003; 112(1-2):121. PubMed ID: 15013284
    [No Abstract]   [Full Text] [Related]  

  • 13. Deep vein thrombosis associated with the new oral contraceptive Yasmin.
    Oo TH
    South Med J; 2009 Sep; 102(9):985-6. PubMed ID: 19668042
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
    Seeger JD; Loughlin J; Eng PM; Clifford CR; Cutone J; Walker AM
    Obstet Gynecol; 2007 Sep; 110(3):587-93. PubMed ID: 17766604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism after high-dose chemotherapy in a patient with Hodgkin's lymphoma receiving the new oral contraceptive ethinylestradiol and drospirenone ("Yasmine").
    Tartarone A; Gallucci G; Cammarota A; Romano G; Ardito R; Di Renzo N
    Bone Marrow Transplant; 2005 Jan; 35(1):103. PubMed ID: 15531905
    [No Abstract]   [Full Text] [Related]  

  • 16. YAZ and the novel progestin drospirenone.
    Mishell DR
    J Reprod Med; 2008 Sep; 53(9 Suppl):721-8. PubMed ID: 18980044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosexual well-being in women using oral contraceptives containing drospirenone.
    Nappi RE; Albani F; Tonani S; Santamaria V; Pisani C; Terreno E; Martini E; Polatti F
    Funct Neurol; 2009; 24(2):71-5. PubMed ID: 19775533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Yasmin as safe as other contraceptive pills?
    Mira Y; Morata C; Vayá A; Ferrando F; Contreras T; Aznar J
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):378-9. PubMed ID: 16959696
    [No Abstract]   [Full Text] [Related]  

  • 19. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.
    Dinger JC; Heinemann LA; Kühl-Habich D
    Contraception; 2007 May; 75(5):344-54. PubMed ID: 17434015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives.
    Med Lett Drugs Ther; 2000 May; 42(1078):42-4. PubMed ID: 10847115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.